BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11293884)

  • 1. Osteopenia in Puerto Ricans with Crohn's disease.
    Chinea B; Rosa A; Oharriz JJ; Ramírez M; Haddock L; Pérez C; Torres EA
    P R Health Sci J; 2000 Dec; 19(4):329-33. PubMed ID: 11293884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.
    Lee N; Fowler E; Mason S; Lincoln D; Taaffe DR; Radford-Smith G
    J Gastroenterol Hepatol; 2007 Jun; 22(6):913-9. PubMed ID: 17565648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients.
    Andreassen H; Hylander E; Rix M
    Am J Gastroenterol; 1999 Mar; 94(3):824-8. PubMed ID: 10086673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
    de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH
    Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone metabolism changes in 100 patients with inflammatory bowel disease].
    Legido J; Gisbert JP; Maté J
    Gastroenterol Hepatol; 2011; 34(6):379-84. PubMed ID: 21664725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative impact of Crohn's disease on bone mineral mass.
    Thodis E; Rossos P; Habal F; Oreopoulos D
    J Musculoskelet Neuronal Interact; 2003 Sep; 3(3):246-50. PubMed ID: 15758348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
    Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malabsorption is a major contributor to underweight in Crohn's disease patients in remission.
    Vaisman N; Dotan I; Halack A; Niv E
    Nutrition; 2006 Sep; 22(9):855-9. PubMed ID: 16928471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low bone mass due to sickle cell anemia: is it becoming a real issue?
    Sadat-Ali M; Al-Elq AH; Sultan O; Al-Turki H; Bukhari R; Al-Mulhim E
    West Afr J Med; 2008 Oct; 27(4):218-23. PubMed ID: 19469399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low bone mineral density in children with Crohn's disease].
    Bourges O; Dorgeret S; Alberti C; Hugot JP; Sebag G; Cézard JP
    Arch Pediatr; 2004 Jul; 11(7):800-6. PubMed ID: 15234375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease.
    Sylvester FA; Leopold S; Lincoln M; Hyams JS; Griffiths AM; Lerer T
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):452-5. PubMed ID: 19249399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in the prevalence and severity of bone disease in thalassaemia.
    Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
    Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
    Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.